Simplex Trading’s Cumberland Pharmaceuticals CPIX Stock Holding History

Simplex Trading’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.1K	Buy	+7,100	New	+$27.4K	﹤0.01%	6654
2025 Q4	–	Sell	-7,100	Closed	-$22K	–	8765
2025 Q3	$22K	Buy	7,100 +4,500	+173%	+$15K	﹤0.01%	7241
2025 Q2	$8K	Sell	2,600 -2,000	-43%	-$9.47K	﹤0.01%	7451
2025 Q1	$19K	Sell	4,600 -7,700	-63%	-$31.9K	﹤0.01%	6607
2024 Q4	$29K	Buy	+12,300	New	+$18.1K	﹤0.01%	6379
2023 Q3	–	Sell	-3,600	Closed	-$5K	–	8799
2023 Q2	$5K	Sell	3,600 -8,500	-70%	-$14.7K	﹤0.01%	7891
2023 Q1	$23K	Buy	+12,100	New	+$28.8K	﹤0.01%	6767
2022 Q3	–	Sell	-700	Closed	-$1K	–	10020
2022 Q2	$1K	Buy	700 +100	+17%	+$231	﹤0.01%	9537
2022 Q1	$1K	Buy	600 +100	+20%	+$333	﹤0.01%	10039
2021 Q4	$2K	Buy	+500	New	+$1.71K	﹤0.01%	9964
2015 Q2	–	Sell	-9	Closed	-$1K	–	5259
2015 Q1	$1K	Buy	+9	New	+$56	﹤0.01%	4426

Other funds holding CPIX

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Simplex Trading's CPIX Position: Q3 2025 in Review

Simplex Trading sold out of Cumberland Pharmaceuticals (CPIX) in Q3 2025, closing a stake of 14,218 shares — an estimated $47.2K sold.

Simplex Trading first reported a position in CPIX in Q4 2022 and held it in 4 quarters. The position peaked at $80K in Q1 2025. 30 funds tracked by Wall St. Rank hold CPIX as of Q3 2025.

Simplex Trading reported no remaining Cumberland Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Simplex Trading sold 14,218 Cumberland Pharmaceuticals shares in Q3 2025, an estimated $47.2K.
Simplex Trading first reported a position in Cumberland Pharmaceuticals in Q4 2022 and held it in 4 quarters.
Simplex Trading's Cumberland Pharmaceuticals position peaked at $80K in Q1 2025.
30 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.